Skip to main content
Caplight Logo









InduPro

InduPro

Private
Seattle, WashingtonHealthcare & Life Scienceshttps://www.induprotx.com/

Last Round

Series B

Aug 12, 2026

Total Funding Raised

$162M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

InduPro is a biotechnology company that develops innovative therapeutics by manipulating protein pairings to create new signaling pathways and logic gates at the cell surface.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

oncology therapeuticsdrug discoveryprotein-based medicinebiotechbispecific antibodiesmultispecific antibodiesantibody drug conjugatesADCmembrane interactomicsMIntcell surface receptorsdrug development platformbiopharmaAI drug discoverycancer research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

InduPro Comparables

Compare InduPro with similar companies based on industry and business-model similarity.

InduPro comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
EpiBiologics
83%
Normunity
83%
Stipple Bio
81%

InduPro Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BAug 12, 2026
Corporate FundingJan 7, 2026
Corporate FundingDec 10, 2025
Series AJun 13, 2024

Key People

Founding team and executive leadership

Prakash Raman

Chief Executive Officer

Executive Team

InduPro Investors

Notable investors and investment history

InduPro investors
InvestorRounds
The Column GroupSeries B, Series A
Vida VenturesSeries B, Series A
The Chernin GroupSeries A
Solasta VenturesSeries B
Emerson CollectiveSeries B, Series A
Euclidean CapitalSeries B, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 70% MoM, reaching 2K.

  • Aug 12, 2026

    $77M round led by The Column Group.

Recent news

Latest coverage and updates

  • is_developingAug 14, 2026

    InduPro, Inc. is developing drugs based on the spatial relationships between proteins on the surface of cells on Aug 14th '26.

  • receives_financingAug 12, 2026

    InduPro, Inc. received financing of $77M in Series B on Aug 12th '26.

InduPro Filings

Explore SEC and related filing metadata, where available.

InduPro filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about InduPro's valuation, stock price, and market status.

Is InduPro a public or private company?

InduPro is a private company.

What is the current stock price of InduPro?

InduPro is a private company with no public stock price. No recent secondary market data is available.

How much is InduPro worth (valuation)?

Valuation information for InduPro is not publicly available.

Can I buy InduPro stock?

InduPro shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was InduPro's last funding round?

InduPro's most recent funding round was Series A on June 13, 2024.

Who are the main investors in InduPro?

Key investors in InduPro include The Column Group, Vida Ventures, The Chernin Group.

Will InduPro IPO soon?

No public IPO plans have been announced for InduPro.

How can I track InduPro secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor InduPro's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSeattle, Washington
Employee Range46
Year Founded2022
Last FundingAug 12, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?